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Bifidobacteria are important members of the human gut flora, especially in infants. Comparative genomic
analysis of two Bifidobacterium animalis subsp. lactis strains revealed evolution by internal deletion of consecutive spacer-repeat units within a novel clustered regularly interspaced short palindromic repeat locus, which
represented the largest differential content between the two genomes. Additionally, 47 single nucleotide
polymorphisms were identified, consisting primarily of nonsynonymous mutations, indicating positive selection
and/or recent divergence. A particular nonsynonymous mutation in a putative glucose transporter was linked
to a negative phenotypic effect on the ability of the variant to catabolize glucose, consistent with a modification
in the predicted protein transmembrane topology. Comparative genome sequence analysis of three Bifidobacterium species provided a core genome set of 1,117 orthologs complemented by a pan-genome of 2,445 genes.
The genome sequences of the intestinal bacterium B. animalis subsp. lactis provide insights into rapid genome
evolution and the genetic basis for adaptation to the human gut environment, notably with regard to catabolism
of dietary carbohydrates, resistance to bile and acid, and interaction with the intestinal epithelium. The high
degree of genome conservation observed between the two strains in terms of size, organization, and sequence
is indicative of a genomically monomorphic subspecies and explains the inability to differentiate the strains by
standard techniques such as pulsed-field gel electrophoresis.
Actinobacteria, Firmicutes, Proteobacteria, and Bacteroidetes
are dominant microbial phyla widely distributed in diverse
ecosystems on the planet (10, 13, 20, 23, 33, 40, 51). Metagenomic analyses of the microbial landscape inhabiting various mammalian environments, notably the human gastrointestinal tract (GIT) and skin, have specifically identified
Actinobacteria as an important and occasionally dominant phylum (18, 21, 33). Among the members of the large, diverse, and
dynamic microbial community residing in the human GIT,
Bifidobacterium is a dominant genus considered beneficial to
humans and includes probiotic strains (live microorganisms
which, when administered in adequate amounts, confer a
health benefit on the host) (11). The population of bifidobacteria in the human intestine varies over time. Following vaginal

delivery, the GIT of healthy newborns is typically colonized by
bifidobacteria, especially in breast-fed infants, during the first
few days of life (12). Interindividual variation, however, is
remarkable in the human infant intestinal flora (41), and dominant genera are not always consistent across metagenomic
analyses of the human gut flora (18, 30, 33, 41). Over time, the
infant intestinal ecosystem becomes more complex as the diet
becomes more diverse, with bifidobacteria typically remaining
dominant until weaning (30).
Bifidobacterium animalis subsp. lactis is a gram-positive lactic acid bacterium commonly found in the guts of healthy
humans and has been identified in the infant gut biota, particularly in ileal, fecal, and mucosal samples (52, 56). Some
strains of B. animalis subsp. lactis are able to survive in the
GIT, to adhere to human epithelial cells in vitro, to modify
fecal flora, to modulate the host immune response, or to prevent microbial gastroenteritis and colitis (4, 15, 20, 40, 52, 56).
Additionally, B. animalis subsp. lactis has been reported to
utilize nondigestible oligosaccharides, which may contribute to
the organism’s ability to compete in the human gut. Carbohydrates resistant to enzymatic degradation and not absorbed in
the upper intestinal tract are a primary source of energy for
microbes residing in the large intestine. The benefits associated
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Snjezana Rendulic,5‡ James L. Steele,3 Jeffery R. Broadbent,6
Taylor Oberg,6 Edward G. Dudley,2 Stephan Schuster,5
Dennis A. Romero,1 and Robert F. Roberts2*

VOL. 191, 2009

B. ANIMALIS SUBSP. LACTIS GENOME SEQUENCES

with probiotic strains of B. animalis subsp. lactis have resulted
in their inclusion in the human diet via formulation into a large
array of dietary supplements and foods, including dairy products such as yogurt. Deciphering the complete genome sequences of such microbes will provide additional insight into
the genetic basis for survival and residence in the human gut,
notably with regard to the ability to survive gastric passage and
utilize available nutrients. Also, these genomes provide reference sequences for ongoing metagenomic analyses of the human environment, including the gut metagenome.
Bifidobacterium animalis subsp. lactis is the most common
bifidobacterium utilized as a probiotic in commercial dairy
products in North America and Europe (22, 38). However,
despite this commercial and probiotic significance, strain-level
differentiation of B. animalis subsp. lactis strains has been
hindered by the high genetic similarity of these organisms, as
determined by pulsed-field gel electrophoresis and other nucleic acid-based techniques (6, 55, 56), and the lack of available
genomic sequence information. The genome sequence of
strain BB-12 (17) is not currently publicly available, and only a
draft genome sequence in 28 contigs is available for strain
HN019 (GenBank project 28807). The complete B. animalis
subsp. lactis genome for strain AD011 (28) was only recently
(2009) published. While this was an important first step, a
single genome does not allow identification of unique targets
for strain differentiation or comparative analyses within the
subspecies.
The objectives of this study were to determine the complete
genome sequences of two B. animalis subsp. lactis strains, the
type strain and a widely used commercial strain, to provide
insights into the functionality of this species and into species
identification and strain specialization.

were annotated at Integrated Genomics, using the ERGO package (Integrated
Genomics, Chicago, IL) without manual curation, and at NCBI.
In silico analyses. The two B. animalis subsp. lactis genomes were aligned
using BioEdit (Isis Biosciences) and SeqMan (DNASTAR, Madison, WI). Single
nucleotide polymorphism (SNP) reports were generated to identify insertions,
deletions, and mutations. Comparative genomic analyses for clusters of orthologous groups (COGs) (51) were carried out by similarity clustering in the ERGO
package and were visualized using MeV (J. Craig Venter Institute, MD) (45).
SNP resequencing. After identification of putative SNPs between the two
genome drafts, primers were designed to amplify regions containing SNPs from
both genomes. PCR amplicons were purified using a Qiaquick kit (Qiagen,
Valencia, CA) and were sequenced at The Pennsylvania State University or the
Davis Sequencing facilities.
CRISPR analyses. Clustered regularly interspaced short palindromic repeat
(CRISPR) loci were identified in the Bl-04 and DSM 10140 genome sequences
by use of Dotter (49). An internal segment of the putative CRISPR locus was
amplified by PCR, using primers 5⬘-TTGGATGCAAGCCCTCAATGAAGC-3⬘
and 5⬘-TGAGGGAAGCCGAACTCAATCACA-3⬘. The PCR amplicons were
subsequently sequenced (Davis Sequencing) from both ends with each primer.
The CRISPR spacers were visualized as two-tone color combinations as previously described (3, 26).
Nucleotide sequence accession numbers. The genome sequences for Bl-04 and
DSM 10140 were deposited at NCBI under accession numbers CP001515 and
CP001606, respectively.

RESULTS
B. animalis subsp. lactis genome. Bl-04 shotgun sequencing
generated 1,824,258 bp assembled in 121 contigs. Complementation by pyrosequencing generated 1,948,770 bp assembled in
16 contigs. Concurrently and independently, DSM 10140 pyrosequencing generated 33⫻ coverage of the 1.9-Mbp genome,
assembled in 30 contigs. Following a few rounds of gap closing
(by contig end pairing), the remaining contigs (3 for Bl-04 and
10 for DSM 10140) from both genome drafts were aligned,
using the Bl-04 optical map as a template. Remaining gaps
were closed subsequently and independently in both genomes.
The distinct sequencing strategies used for the two genomes
generated comparable assemblies, with the exception of one
misassembly in the pyrosequencing-only genome draft. Upon
comparison of the two genomes, a total of 211 putative SNPs
were identified. Fourteen of the putative SNPs were located in
rRNA operons or insertion sequence (IS) elements and were
not resequenced. After resequencing of the remaining 197
SNPs, 150 were found to be the results of sequencing errors,
while 47 SNP sites were confirmed.
Overall, the Bl-04 and DSM 10140 genomes are 1,938,709 bp
and 1,938,483 bp, respectively. Using the largest genome as a
reference (Bl-04), 1,655 open reading frames (ORFs) were
identified, and putative functions were assigned to 1,072 of
them, which is typical across sequenced Bifidobacterium genomes (Table 1). The features of the B. animalis subsp. lactis
genomes are detailed in Table 1 and in Fig. SA in the supplemental material.
The origin and terminus of replication in the B. animalis
subsp. lactis genome were predicted (see Fig. SA and SB in the
supplemental material) based on dnaA (Balac_0001), DnaA
boxes, and base composition asymmetry between the leading
and lagging strands (16, 24, 34). The putative oriC origin of
replication was identified in an AT-rich intergenic region upstream of dnaA, in the vicinity of a cluster of hypothetical
DnaA boxes (see Fig. SB in the supplemental material). Similar putative oriC’s with comparable DnaA boxes were also
identified in other bifidobacterial genomes (see Fig. SB in the
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MATERIALS AND METHODS
Bacterial strains. Bifidobacterium animalis subsp. lactis Bl-04 (also known as
DGCC2908 and RB 4825) was originally isolated from a fecal sample from a
healthy adult, is a widely used commercial strain, and has been deposited at the
American Type Culture Collection safe deposit as strain SD5219. DSM 10140,
which is the B. animalis subsp. lactis type strain, was originally isolated from a
commercial product (39) and was obtained from the Deutsche Sammlung von
Mikroorganismen und Zellkulturen GmbH (Braunschweig, Germany). Additionally, B. animalis subsp. lactis strains Bi-07 (ATCC SD5220), HN019, and
B420, from the Danisco Global Culture Collection, were used. DSM 10140 was
propagated at 37°C anaerobically in LL (31). All other cultures were propagated
at 37°C anaerobically in MRS supplemented with 0.05% cysteine.
Genome sequencing. The B. animalis subsp. lactis Bl-04 genome draft sequence was obtained by whole-genome shotgun sequencing carried out at Macrogen (Rockville, MD). A DNA library was prepared in pC31 and shotgun
sequenced using an ABI 3730XL sequencer (Roche, Nutley, NJ), targeting 6⫻
coverage. To complement the Bl-04 draft genome, a 454 pyrosequencing run was
performed, targeting 15⫻ coverage, using a GS-20 sequencer.
Independently, the B. animalis subsp. lactis DSM 10140 genome draft was
sequenced at The Pennsylvania State University, using 454 pyrosequencing targeting 30⫻ coverage, followed by de novo assembly in Newbler (Roche).
Concurrently, an optical map was generated for the Bl-04 strain at OpGen
(Madison, WI), using NotI. Assembled contigs were aligned with the optical
map, and remaining gaps were closed by walking across PCR products. PCR
amplicons were sequenced at the Huck Institute Nucleic Acid Facility at The
Pennsylvania State University, using 3⬘ BigDye-labeled dideoxynucleotide
triphosphates (v 3.1 dye terminators; Applied Biosystems, Foster City, CA) and
running on an ABI 3730XL DNA analyzer using the ABI data collection program (v 2.0), or at Davis Sequencing (Davis, CA). Data were analyzed with ABI
sequence analysis software (version 5.1.1). Sequencing reactions were performed
using protocol 4303237 from Applied Biosystems. Complete genome sequences
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TABLE 1. General characteristics of selected bifidobacterial genomesa

Strain

B. animalis subsp. lactis
Bl-04
B. animalis subsp. lactis
DSM 10140
B. adolescentis ATCC
15703
B. longum NCC2705
a

Genome
size (bp)

Coding
%

% G⫹C

Avg ORF
length
(bp)

No. of
predicted
ORFs

No. of ORFs
with assigned
function

No. of
COG
matches

No. of
Pfam
domains

No. of
rRNA
operons

No. of
tRNAs

No. of
transposases

1,938,709

90.45

60.48

1,053

1,655

1,072

773

890

4

52

9

1,938,483

90.34

60.48

1,056

1,658

1,071

773

890

4

51

9

2,089,645

87.57

59.18

1,122

1,631

1,165

791

936

5

55

15

2,260,266

86.07

60.13

1,503

1,729

1,305

839

969

4

54

1

Numbers were extracted from the ERGO Database at the time of analysis.

terestingly, the importance of long-chain-fatty-acid–coenzyme
A synthetases in bifidobacteria has been noted previously (46).
INDEL3 is a 214-bp sequence within the CRISPR locus which
is present in Bl-04 (bp 1,512,373 to 1,512,586) but absent in the
DSM 10140 genome, and it corresponds to three repeat-spacer
units. INDEL4 is a 54-bp sequence which is present in an
intergenic region in the DSM 10140 genome (bp 1,715,507 to
1,715,560) but absent in the Bl-04 genome.
Overall, notwithstanding the 47 SNPs and the 443 bp of
INDELs, the two genomes were 99.975% identical. In addition
to the two complete genome sequences, optical mapping was
used to analyze the genome layouts of four B. animalis subsp.
lactis strains. The highly similar optical maps of this strain set
(comprised of the type strain, commercial strains, and isolates
used in functional and clinical studies) indicate a high degree
of genome conservation in terms of size, organization, and
sequence (Fig. 1). The lack of polymorphism observed is indicative of a genomically monomorphic subspecies.
Comparative genomic analysis of bifidobacteria. Analysis of
the distribution of annotated ORFs over COG categories revealed a high overall conservation of COG representation
across B. animalis subsp. lactis, B. longum, and B. adolescentis
(Table 1), which belong to three different Bifidobacterium clusters (14, 52, 53). Specifically, the top four functional categories,
namely, general prediction, translation, carbohydrate metabo-

FIG. 1. Alignment of B. animalis subsp. lactis genomes. Differences observed between the two B. animalis subsp. lactis genomes are shown in
the figure. (A) SNPs are indicated using bars, with noncoding SNPs at the top, synonymous SNPs in the middle, and nonsynonymous SNPs at the
bottom. INDELs are shown by arrows, with insertions in the Bl-04 genome shown on top and insertions in the DSM 10140 genome shown on the
bottom. (B) Optical maps of various B. animalis subsp. lactis strains, visualized using OpGen MapViewer, based on a NotI digest. The first two
optical maps were generated in silico (indicated by asterisks) based on the genome sequences. The other optical maps represent experimental data.
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supplemental material), were consistent with previously observed degeneracy at certain sites, and reflected the high G⫹C
content of the genome (24, 34). These conserved elements
might be used to locate the origin of replication in Bifidobacterium species and other genomes of Actinobacteria, since GC
skew analysis alone does not necessarily identify an unequivocal oriC (46).
Comparative analysis of two B. animalis subsp. lactis genomes. Comparison of the two B. animalis subsp. lactis genomes revealed nearly perfect alignment. Of the 47 SNPs validated for the two genome sequences, 39 were in predicted
coding sequences and 8 were in intergenic regions (Fig. 1; see
Table S2 in the supplemental material). Of the 39 coding
SNPs, 31 represent nonsynonymous mutations and 8 are synonymous (Fig. 1), indicating positive selection and/or recent
divergence. Four distinct insertion/deletion sites (INDELs)
were also identified, totaling 443 bp (see Table S3 in the supplemental material). INDEL1 is a 121-bp sequence encoding
tRNA-Ala-GGC which is present in the Bl-04 genome (bp
881,420 to 881,540) but absent in the DSM 10140 genome.
INDEL2 is a 54-bp sequence within the long-chain-fatty-acid–
coenzyme A ligase gene (Balac_0771; EC 6.2.1.3; COG1022)
which is present in the DSM 10140 genome (bp 902,893 to
902,946) but absent in the Bl-04 genome. INDEL2 yields an
in-frame deletion of 18 amino acids in the Bl-04 protein. In-
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lism, and amino acid metabolism, were identical, which is typical of lactic acid bacteria (35, 37). However, fewer ORFs were
associated with carbohydrate utilization in B. animalis subsp.
lactis than in B. longum and B. adolescentis. Overall, most genes
(1,117 [67%]) were conserved in all three species, representing
the “core” bifidobacterial genome (see Fig. SC in the supplemental material), whereas 416 (25%), 368, and 298 genes were
unique to B. animalis subsp. lactis, B. longum, and B. adolescentis, respectively. Interestingly, a relatively small proportion
of genes were shared between two genomes only, while a larger
proportion of genes were unique to each of the three genomes
examined, suggesting distinct speciations (see Fig. SC in the
supplemental material). Alignment of the three chromosomes
indicated that B. animalis subsp. lactis shares a relatively high
level of synteny with B. adolescentis but exhibits little colinearity with B. longum (see Fig. SD in the supplemental material).
This further confirms the observed differences between the
genomes of B. longum and B. adolescentis (47).
Comparative analysis of gene conservation across the three
Bifidobacterium species through BLASTp (see Table S1 in the
supplemental material) revealed eight areas containing consecutive sets of ORFs present in B. animalis subsp. lactis and
absent in both B. adolescentis and B. longum (Fig. 2). Notably,
a prophage remnant is located in area 5, including a phagerelated integrase gene (Balac_1179; COG0582) and a phagerelated prohead protein gene (Balac_1191; COG3740). Although there is only anecdotal evidence of bacteriophages in
bifidobacteria (48), a previous analysis of bifidobacterial genome sequences revealed the presence of prophages inte-
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grated in a tRNAMet gene (53, 54). The observed remnants of
a prophage-like element in the B. animalis subsp. lactis genome
do not seem to be adjacent to a tRNAMet sequence. An eps
cluster with a low GC content was identified in area 7 (Balac_
1383 to Balac_1391) and may be involved in the synthesis of
membrane-associated exopolysaccharides. Two genes potentially involved in oxalic acid catabolism (13), namely, oxc (Balac_1453) and frc (Balac_1449), which encode an oxalyl-coenzyme A decarboxylase (EC 4.1.1.8) and a formyl-coenzyme A
transferase (EC 2.8.3.16), respectively, were identified in area
8.
Analysis of B. animalis subsp. lactis CRISPR locus. A novel
CRISPR-Cas system, Bala1, was identified in the B. animalis
subsp. lactis genome in area 6 (Fig. 2), and this system is
different from other CRISPR loci previously identified in bifidobacteria. It is the ninth CRISPR family identified in lactic
acid bacterial genomes and the fourth CRISPR family identified in bifidobacteria, in addition to Blon1 (in B. longum),
Lhel1 (in B. adolescentis), and Ldbu1 (present in Bifidobacterium catenulatum) (25). Novelty was observed in terms of both
the CRISPR repeat sequence and cas (CRISPR-associated)
gene content. In Bl-04, the typical 36-bp CRISPR repeat, 5⬘ATCTCCGAAGTCTCGGCTTCGGAGCTTCATTGAGG
G-3⬘, which is partially palindromic, is present 23 times and
separated by 22 unique spacer sequences (Fig. 3; see Fig. SF in
the supplemental material). The typical repeat sequence is
conserved in the first 21 repeats, while the last 2 have SNPs
(see Fig. SF in the supplemental material), notably at the 3⬘
end, as previously shown in other CRISPR systems (26). Two
remnant CRISPR repeats were also identified between cas2
and csb1 (Fig. 3). The co-occurrence of remnant CRISPR
repeats and a typical CRISPR repeat-spacer array has been
observed previously, notably in Streptococcus thermophilus
CRISPR3 (26) and B. adolescentis (25). Six cas genes were
identified downstream of the repeat-spacer region, including
the cas1 universal nuclease gene (Balac_1308; COG1518;
TIGR00287), the cas2 endonuclease gene (Balac_1307;
COG1343; TIGR01573), and the cas3 helicase gene (Balac_
1304; COG1203; TIGR02621). Additionally, three novel putative cas genes, csb1 to -3 (Cas subtype Bifidobacterium Bala1,
with nomenclature derived from reference 23), were also identified in this CRISPR locus. Two of them, csb1 (Balac_1306)
and csb2 (Balac_1305), contain cas-type conserved elements,
i.e., cas_GSU0053 and cas_GSU0054, respectively. The spacer
size varied from 34 to 39 bp. Some Bl-04 CRISPR spacers
showed similarity to viral sequences (S3 homology with Streptomyces phage phi-BT1 AJ550940, S17 homology with frog
virus sequence AY548484, and S20 homology with a phage
capsid protein in Chromohalobacter salexigens CP000285)
and metagenome-derived sequences (S19 homology with human gut metagenome BABA01032251 and S20 homology with
marine metagenome AACY021620797). However, the analysis
of CRISPR spacers was limited by the absence of bifidobacterial phage sequences in public databases.
While the Bala1 CRISPR locus was identified in both Bl-04
and DSM 10140 (Fig. 3), polymorphism was observed in terms
of spacer content. Although the spacer contents were identical
at both the leader and the trailer end of the locus, three
consecutive internal repeat-spacer units were unique to Bl-04
(Fig. 3). The Bala1 CRISPR locus was sequenced for several B.

Downloaded from http://jb.asm.org/ on April 21, 2016 by UTAH STATE UNIV

FIG. 2. Comparative genomic analysis of bifidobacteria. Sequences
homologous to B. animalis subsp. lactis (Bla) proteins are shown in
black, whereas the absence of a homolog in the B. adolescentis ATCC
15703 (Bad) or B. longum NCC2705 (Blo) genome appears in white,
represented using MeV. (Left) Data are presented in chromosomal
ORF order, with the origin of replication at the top and with numbers
indicating locations of areas of unique content in B. animalis subsp.
lactis. (Right) Hierarchical representation of homologs across the
three genomes.
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animalis subsp. lactis strains, and spacer content analysis revealed only two versions of the CRISPR locus, as seen in the
two genomes, with the presence or absence of three consecutive internal repeat-spacer units (Fig. 3). The Bala1 CRISPR
locus was subjected to PCR amplification from several bifidobacterial species, including the B. animalis subsp. animalis
type strain. This locus was present exclusively in B. animalis
subsp. lactis strains and was absent in B. animalis subsp. animalis, B. longum, B. adolescentis, B. dentium, B. catenulatum,
Bifidobacterium breve, and Bifidobacterium bifidum, suggesting
that it is subspecies specific. Interestingly, the GC content of
the Bala1 CRISPR locus was approximately 49.74%, while that
of the genome is 60.19%, suggesting that it may have been
acquired laterally from a low-GC microbe, as previously discussed for CRISPR loci (19, 25).
DISCUSSION
The relatively small size of the B. animalis subsp. lactis genome compared to those of other bifidobacteria is consistent
with a genome simplification process that reduces biosynthetic
capabilities and favors the retention and acquisition of genes
involved in the utilization of a broad repertoire of carbon and
nitrogen sources (35, 37). This is typical of the genomic evolution of microbes that live in nutritionally rich environments,
such as the human gut, and that rely on the host and other
members of the intestinal flora for energy sources and metabolic intermediates (35, 37). This likely explains the smaller
number of hydrolases in B. animalis subsp. lactis than in B.
longum and B. adolescentis (see Table S4 in the supplemental
material). Notably, the genes involved in the catabolism of
human milk oligosaccharides in B. longum subsp. infantis (47)
and in the degradation and utilization of mucin (endo-␣-Nacetylgalactosaminidase) were not identified. Also, unlike the
case for most bacteria, ABC transporters do not appear in the
typical operon configuration, and only two copies of a carbohydrate-specific ATP-binding protein, Balac_0062 (COG1129)
and Balac_1610 (COG3839), were identified in Bifidobacterium animalis subsp. lactis. No phosphotransferase system
(PTS) component was identified, contradicting a previous report of fructose-PTS activity in the DSM 10140 strain (42) and

in contrast to the presence of PTS in B. longum and B. adolescentis.
While the number of carbohydrate hydrolases is smaller for
B. animalis subsp. lactis, the variety of hydrolases present suggests the ability to utilize a wide range of complex carbohydrates, including milk galactosides and undigestible plant-derived oligosaccharides (see Table S4 in the supplemental
material). This is consistent with a previous report that genes
in the carbohydrate transport and metabolism COG are overrepresented in the human gut microbiome (30). This may also
reflect the strong influence of the host diet on bacterial gut
communities in mammals (33).
Additionally, genes involved in the organism’s adaptation
to and survival in the human GIT were identified. Specifically, two paralogs encoding putative N-acetylmuramidases
(COG3757; Balac_1516 and Balac_1517), which may be involved in the degradation of bacterial cell wall components
available in the intestinal environment, were identified. Four
genes encoding putative cell surface proteins that could be
involved in interactions with human epithelial cells were identified in the B. animalis subsp. lactis genomes, including two
putative collagen adhesion proteins (encoded by capA [Balac_
1456 and COG4932] and capB [Balac_1484]), an elastin-binding protein (encoded by ebpS), and a fibronectin-binding protein (encoded by fbp [Balac_0271]). A typical LPXTG anchor
motif was identified only in CapB (LPLTG). An alternative
putative anchor motif, VAATG, was identified in silico in the
vicinity of a poly(R) sequence at the C termini of CapA and
Fbp. The presence of two distinct sortase-encoding genes,
namely, srtB (Balac_1349) and srtA (Balac_1485), in the genome of B. animalis subsp. lactis is consistent with the presence
of two distinct anchor motifs.
Numerous genes commonly associated with the stress response were identified in the B. animalis subsp. lactis genome
(see Table S5 in the supplemental material). Notably, a bile
salt hydrolase gene, bsh (Balac_0863; EC 3.5.1.24), encoding a
member of the Ntn-PVA family of enzymes (COG3049), was
identified. This gene family is enriched in the human gut microbiome (27) and is likely involved in the ability of B. animalis
subsp. lactis to tolerate bile and to survive in the human gut
environment.
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FIG. 3. Overview of B. animalis subsp. lactis CRISPR locus. The Bala1 CRISPR locus, as it appears in the genome, is shown at the top, with
the repeat-spacer region on the left (repeats are represented as black diamonds, and spacers are represented as gray boxes) and cas genes on the
right. The repeat-spacer region is shown below for Bl-04 and DSMZ 10140, with repeats shown as black diamonds, spacers shown as numbered
gray boxes, the leader shown as a white box, and the terminal repeat shown as a black diamond annotated with a “T.” The bottom panel shows
a CRISPR spacer overview where repeats are not included and only spacers are represented, using two-color combinations.
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Genomic content was compared across members of the following three distinct Bifidobacterium phylogenetic clusters: B.
adolescentis, B. longum, and B. animalis subsp. lactis (a member
of the Bifidobacterium pseudolongum group) (14, 53). Comparative analysis revealed a high degree of conservation and synteny overall (Fig. 2; see Fig. SD in the supplemental material),
as previously observed in Bifidobacterium genomes (47). However, there are significant, functionally relevant differences,
notably in CRISPR content, catabolism of dietary compounds,
cell surface proteins and polysaccharides, and prophages. Notably, cell surface proteins encoded in the B. animalis subsp.
lactis genome may be involved in its ability to adhere to human
intestinal epithelial cells (20) and may possess immunomodulation properties.
Overall, it appears that the genomes of the B. animalis
subsp. lactis strains included in this study are highly monomorphic, consistent with previous reports indicating a high degree
of similarity among B. animalis subsp. lactis strains isolated
from infant samples and various commercial products, as determined by pulsed-field gel electrophoresis (6, 55, 56), which
may suggest clonal ancestry.
Comparison of the Bl-04 genome to the recently published
genome sequence of B. animalis subsp. lactis AD011 (28) revealed the AD011 genome to be 5,014 bp shorter than the
Bl-04 genome and indicated a marked difference in assembly
between the two genomes. An advantage of the approach
taken in the current work—independently sequencing two related strains—is the increased confidence and ability to identify strain-level differences, which has been a challenge for this
particular subspecies. In this particular case, the number of
SNPs initially identified between Bl-04 and DSM 10140 was
decreased approximately fivefold by resequencing. Thus, by
sequencing two genomes independently, using both traditional
and pyrosequencing methods, and resequencing SNPs regardless of quality score, a low error rate (approximately
0.00035%) was obtained, leading to increased confidence in
the genome sequences. Comparison of the Bl-04 genome to
the HN109 draft genome (currently in 28 contigs) did not
reveal any novel content.
Despite the genetic homogeneity among B. animalis subsp.
lactis strains, interstrain functional differences have been observed, such as variability in immunogenic properties (15) and
the ability to catabolize glucose (5). Interestingly, a SNP was
identified in glcU (Balac_1097; COG4975), encoding a putative
glucose uptake protein. Bl-04 has a reduced ability to grow
using glucose as the primary carbohydrate source, which is
linked to a significant reduction in its ability to transport glucose into the cell (5). In silico analysis of the putative transmembrane domains of the two glcU variants indicated that the
nonsynonymous CGT (Arg in Bl-04)-to-GGT (Gly in DSM
10140) mutation impacts the predicted structural arrangement
of the resulting proteins in the cell membrane (see Fig. SE in
the supplemental material). Perhaps this SNP resulting in the
loss of the ability to transport glucose is indicative of rapid
evolution driven either by the lack of selective pressure to
maintain a functional glucose transporter in the human gut
environment, where glucose is likely absent due to its absorption in the upper GIT, or by selective pressure against maintaining an arguably useless gene.
While it is difficult to study the evolutionary changes in such

monomorphic bacterial genomes, SNPs and INDELs provide
insights into the evolution and diversity of clonal bacteria (10).
Based on the size and number of SNPs identified in these two
B. animalis subsp. lactis genomes (32, 43, 57), these strains are
separated by 1,268 to 304,414 generations, or 6 to 1,522 years
(based on 200 generations per year). The primary observed
genomic difference between the two strains consists of three
CRISPR repeat-spacer units present in the Bl-04 genome and
absent in the DSM 10140 genome. CRISPR represents a family of repeated DNA elements that provide acquired immunity
against foreign genetic elements (3, 7, 36, 50). Since it was
previously shown that CRISPR loci evolve primarily by polarized addition of novel spacers at the leader end of the locus
and by internal deletion of contiguous vestigial spacers (3, 9,
26), the observed difference between the two B. animalis subsp.
lactis genomes is likely the result of an internal deletion within
the Bala1 CRISPR locus. This suggests that Bl-04 is the ancestral strain from which a variety of B. animalis subsp. lactis
clonal offspring may have recently derived.
The determination of two B. animalis subsp. lactis genome
sequences provides insights into the genetic basis for survival in
the human GIT. The ability of microbes to survive in the
human environment has been associated with resistance to
acid and bile, as well as their opportunistic capacity to utilize
undigested dietary compounds. This can be achieved by encoding the enzymatic machinery necessary to catabolize either a
wide range of carbohydrates or niche-specific nutrients, as documented for the cariogenic organism Streptococcus mutans in
the oral cavity (1), the adaptation of Lactobacillus plantarum to
a variety of environmental niches (29), the presence of Lactobacillus johnsonii and Lactobacillus acidophilus in the GIT (2,
44), and the residence of B. longum in the colon (46). The
comparison of two nearly identical genome sequences revealed
rapid evolution via internal deletion of three consecutive repeat-spacer units within a CRISPR locus, three small INDELs,
and 47 SNPs, including a nonsynonymous mutation resulting in
the loss of the ability to utilize glucose efficiently, perhaps
resulting from directed evolutionary pressure. In addition, the
availability and analyses of these genome sequences may allow
for the development of molecular methods for strain differentiation and will aid in metagenomic analyses of the human
microbiome.
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